Comments
- No comments found
- Urine volume and change in estimated GFR
- Home
-
About ISN
- Membership
- News
- Topics
- Programs
- Regions
- Initiatives
- Publications
-
Education
-
Education Topics
- Pathology Topics
- Acute Kidney Injury
- Anemia, Iron and trace elements
- Chronic Kidney Disease
- Diabetes
- Fluid and Electrolytes
- General Nephrology
- Global Nephrology
- Glomerular Disease
- Hemodialysis
- Hypertension
- Infections
- Interventional Nephrology
- Mineral and bone disorders
- Nutrition and Hydration
- Peritoneal Dialysis
- Systemic Disease
- Transplantation
- Research Methodology
- Urolithiasis
- Basic Science
-
Education Topics
- Events
Sunday, 13 April 2014 16:24
Balance of Thymosin Beta4 and AcSDKP - A Novel Target for Fibrosis audioicon
By Agnes FogoThis presentation was given by Agnes B. Fogo, ISN Pathology Committee Chair. It was given during the ISN Nexus Symposium 2014 held in Bergamo, Italy on April 3-6, 2014. The focus this year was on the New era of drug discovery and clinical trials in kidney disease.
Additional Info
- Language: English
- Contains Audio: Yes
- Content Type: Presentations
- Source: ISN
- Event: Nexus
- Year: 2014
- Members Only: No
Read 964 times
Last modified on Thursday, 17 April 2014 21:52
Published in
Basic Science
Tagged under
Latest from Agnes Fogo
Related items
- Drug discovery in kidney disease: from serendipity to rationality
- Fellow: Kamonwan Tangvoraphonkchai From Thailand
- RESULTS OF ARTS-DN: A RANDOMIZED STUDY TO ASSESS THE SAFETY AND EFFICACY OF FINERENONE IN PATIENTS WITH TYPE 2 DIABETES AND DIABETIC NEPHROPATHY
- Patients, Research and Drugs audioicon
- Interaction between academia, industry and government audioicon
More in this category:
« Novel Drugs, Novel Biologics audioicon
Smad3 for Renal Fibrosis audioicon »
|
Global Operations Center Rue des Fabriques 1 |
Americas Operations Center 340 North Avenue 3rd Floor |
Administrator Login
Leave your comments
Post comment as a guest